|
⚲
|
| Keyboard |
| Matthew Patterson | |
|---|---|
| Firm | |
| Address | 201 Haskins Way, Suite 300 South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Addition Therapeutics Inc | 021-567798 | Director | 28.0 M of 28.0 M |
||
| Remix Therapeutics Inc | 021-501562 | Director | 13.7 M of 90.0 M |
||
| Confluencecx SPV Escampa A Series of Atomizer LLC | 021-468527 | Director | 0.4 M of 0.4 M |
||
| Confluencecx SPE29 LLC | 021-397579 | Executive Officer | 0.3 M of 0.3 M |
||
| Audentes Therapeutics Inc | 021-249874 | Executive Officer | 65.0 M of 65.0 M |
||
| Audentes Therapeutics Inc | 021-246838 | Executive Officer | |||
| Audentes Therapeutics Inc | 021-230835 | Executive Officer | 42.5 M of 42.5 M |
||
| Amicus Therapeutics Inc | 021-150076 | Executive Officer | 31.3 M of 31.3 M |
||
| Related People Network |
|---|
| Network #203 at Amicus Therapeutics Inc — files alongside 16 co-filers |